Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?

J Pharmacol Exp Ther. 2005 Apr;313(1):260-7. doi: 10.1124/jpet.104.077768. Epub 2004 Dec 2.

Abstract

Cyclic AMP is the prototypical second messenger of beta-adrenergic receptors, but recent findings have questioned its role in mediating smooth muscle relaxation upon beta-adrenergic receptor stimulation. We have investigated the signaling mechanisms underlying beta-adrenergic receptor-mediated relaxation of rat urinary bladder. Concentration-response curves for isoproterenol-induced bladder relaxation were generated in the presence or absence of inhibitors, with concomitant experiments using passive tension and KCl-induced precontraction. The adenylyl cyclase inhibitor 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22,536; 1 microM), the protein kinase A inhibitors 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7; 10 microM), N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89; 1 microM), and Rp-adenosine 3',5'-cyclic monophosphorothioate (Rp-cAMPS; 30 microM), and the guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ; 3 microM) produced only minor if any inhibition of relaxation against passive tension or KCl-induced precontraction. Among various potassium channel inhibitors, BaCl2 (10 microM), tetraethylammonium (3 microM), apamin (300 nM), and glibenclamide (10 microM) did not inhibit isoproterenol-induced relaxation. Some inhibition of the isoproterenol effects against KCl-induced tone but not against passive tension was seen with inhibitors of calcium-dependent potassium channels such as charybdotoxin and iberiotoxin (30 nM each). A combination of SQ 22,536 and ODQ significantly inhibited relaxation against passive tension by about half, but not that against KCl-induced tone. Moreover, the combination failed to enhance inhibition by charybdotoxin against KCl-induced tone. We conclude that cAMP and cGMP each play a minor role in beta-adrenergic receptor-mediated relaxation against passive tension, and calcium-dependent potassium channels play a minor role against active tension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Adenine / analogs & derivatives*
  • Adenine / pharmacology
  • Adenylyl Cyclase Inhibitors
  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Cyclic AMP / physiology*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Enzyme Inhibitors / pharmacology
  • Guanylate Cyclase / antagonists & inhibitors
  • In Vitro Techniques
  • Isoproterenol / pharmacology*
  • Male
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects
  • Potassium Channels / agonists
  • Potassium Chloride / pharmacology
  • Rats
  • Signal Transduction / drug effects
  • Urinary Bladder / drug effects*

Substances

  • Adenylyl Cyclase Inhibitors
  • Adrenergic beta-Agonists
  • Enzyme Inhibitors
  • Potassium Channels
  • 9-(tetrahydro-2-furyl)-adenine
  • Potassium Chloride
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Guanylate Cyclase
  • Adenine
  • Isoproterenol